Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 21:00:02 10/05/2024 BST 5-day change 1st Jan Change
130.1 USD -0.13% Intraday chart for Merck & Co., Inc. +2.00% +19.30%
Sales 2024 * 64.11B 5,120B Sales 2025 * 68.6B 5,478B Capitalization 329B 26,309B
Net income 2024 * 19.51B 1,558B Net income 2025 * 22.27B 1,779B EV / Sales 2024 * 5.43 x
Net Debt 2024 * 18.91B 1,510B Net Debt 2025 * 7.6B 607B EV / Sales 2025 * 4.91 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
14.6 x
Employees 71,000
Yield 2024 *
2.38%
Yield 2025 *
2.52%
Free-Float 70.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.13%
1 week+2.00%
Current month+0.65%
1 month+2.61%
3 months+3.67%
6 months+28.28%
Current year+19.30%
More quotes
1 week
126.76
Extreme 126.76
131.51
1 month
124.50
Extreme 124.5
132.80
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 31/03/14
Director of Finance/CFO 55 31/12/89
Chief Tech/Sci/R&D Officer 55 31/07/20
Members of the board TitleAgeSince
Director/Board Member 63 26/11/07
Director/Board Member 67 31/08/15
Director/Board Member 69 28/02/18
More insiders
Date Price Change Volume
10/05/24 130.1 -0.13% 5,722,627
09/05/24 130.2 +0.52% 9,216,740
08/05/24 129.6 -0.64% 6,659,121
07/05/24 130.4 +2.20% 6,682,316
06/05/24 127.6 +0.05% 6,551,962

Delayed Quote Nyse, May 10, 2024 at 09:00 pm

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus